首页> 美国卫生研究院文献>Canadian Medical Association Journal >Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment
【2h】

Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment

机译:特发性肺纤维化:发病机理和治疗现状的最新了解

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

IDIOPATHIC PULMONARY FIBROSIS (IPF) is a progressive and lethal pulmonary fibrotic lung disease. The diagnostic histological changes are called usual interstitial pneumonia and are characterized by histological temporal heterogeneity, whereby normal lung tissue is interspersed with interstitial fibrosis, honeycomb cysts and fibroblast foci. Pulmonary functions show restricted volumes and capacities, preserved flows and evidence of decreased gas exchange. High-resolution computed axial tomography demonstrates evidence of fibrosis and lung remodelling such as honeycomb cysts and traction bronchiectasis. There is no known effective treatment for IPF, but lung transplantation improves survival.
机译:特发性肺纤维化(IPF)是一种进行性和致命性的肺纤维化性肺疾病。诊断性组织学改变称为通常的间质性肺炎,其特征是组织学上的时间异质性,从而正常肺组织散布着间质纤维化,蜂窝状囊肿和成纤维细胞灶。肺功能显示出容量和容量受限,流量保持不变以及气体交换减少的迹象。高分辨率计算机轴向断层扫描显示纤维化和肺重构的证据,例如蜂窝囊肿和牵引性支气管扩张。尚无IPF的有效治疗方法,但肺移植可提高生存率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号